Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-005144-14Phase 4Active
Phase 4, open-label trial of del Nido cardioplegia in cardiac morbidity (2 arms), sponsored by Dr. Forteza Gil. Primary endpoint: Acute cardiovascular event. Started Apr 2018; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-005144-14.